|
[1]
|
中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
|
|
[2]
|
Hu, H.J., Wang, X.H., Zhang, T.Q., et al. (2022) PLK1 Promotes Cholesterol Efflux and Alleviates Atherosclerosis by up-Regulating ABCA1 and ABCG1 Expression via the AMPK/PPARγ/LXRα Pathway. Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids, 1867, Article ID: 159221. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wagner, N. and Wagner, K.D. (2023) Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease. Inter-national Journal of Molecular Sciences, 24, Article 2345. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
陈成, 张旺生, 陈铃, 等. 畅脉乐Ⅱ胶囊对血瘀型颈动脉粥样硬化患者CRP、IL-6及血栓相关参数的影响[J]. 山西中医, 2022, 38(5): 12-15.
|
|
[5]
|
赵晶, 秦合伟, 李彦杰, 等. 血管软化丸调控PI3K/Akt/mTOR通路影响细胞自噬及抗动脉粥样硬化的作用机制研究[J]. 中华中医药学刊, 2020, 38(1): 65-69, 268-270.
|
|
[6]
|
翁一玲, 李煌, 卓辰茜, 等. 基于UPLC-QE-MS技术的畅脉乐胶囊化学成分分析及其抗脑血栓的网络药理学研究[J]. 中国现代药物应用, 2022, 16(21): 173-178.
|
|
[7]
|
Zhang, H., Ge, S., Ni, B., et al. (2021) Augmenting ATG14 Alleviates Atherosclerosis and In-hibits Inflammation via Promotion of Autophagosome-Lysosome Fusion in Macrophages. Autophagy, 17, 4218-4230. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
曹乾. 在ApoE-/-小鼠中青蒿素通过AMPK/mTOR/ULK1促进巨噬细胞自噬减轻动脉粥样硬化机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2021.
|
|
[9]
|
鲍友利, 曹寅, 吴鸿飞. “瓜蒌-薤白”药对诱导自噬抑制NLRP3炎症小体激活减轻RAW264.7巨噬细胞炎症反应[J]. 中国中药杂志, 2023, 48(10): 2820-2828.
|
|
[10]
|
Alexander, Y., Osto, E., Schmidt-Trucksäss, A., et al. (2021) Endothelial Function in Cardiovascular Medicine: A Consensus Paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Micro-circulation, and Thrombosis. Cardiovascular Research, 117, 29-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
曹程浩, 董晓瑞, 黄斌. 丹参饮合二陈汤加减对颈动脉粥样硬化血管内膜损伤的保护作用[J]. 中国实验方剂学杂志, 2021, 27(7): 86-91.
|
|
[12]
|
Zhang, F., Guo, X., Xia, Y. and Mao, L. (2021) An Update on the Phenotypic Switching of Vascular Smooth Muscle Cells in the Pathogenesis of Atherosclerosis. Cellular and Molecular Life Sciences, 79, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Munteanu, C. (2023) Hydrogen Sulfide and Oxygen Homeosta-sis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives. International Journal of Molecular Sciences, 24, Article 8376. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
杨天睿, 苗云波, 段靳岚, 等. 血液生化指标与颈动脉粥样硬化斑块稳定性的相关性研究[J]. 中华老年心脑血管病杂志, 2022, 24(3): 237-239.
|
|
[15]
|
杨雅雯, 夏敏, 吴芬, 等. Rho相关卷曲螺旋蛋白激酶1在动脉粥样硬化血管壁中的表达及其与基质金属蛋白酶2及转化生长因子1的相关性[J]. 中华老年多器官疾病杂志, 2023, 22(1): 53-58.
|
|
[16]
|
Nasiri-Ansari, N., Spilioti, E., Kyrou, I., et al. (2022) Estro-gen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Athero-sclerotic Plaque Vulnerability. International Journal of Molecular Sciences, 23, Article 10960. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
王建民, 孟蓓, 王胜利, 等. 通窍活血汤对动脉粥样硬化大鼠SIRT1/PGC1α通路及斑块稳定性的影响[J]. 中国老年学杂志, 2023, 43(12): 3009-3013.
|
|
[18]
|
刘婷, 于红红, 王文佳, 等. 基于PPARγ/LXRα/ABCG1通路探讨黄连解毒汤对泡沫细胞脂质蓄积的干预作用[J]. 时珍国医国药, 2023, 34(4): 838-842.
|
|
[19]
|
Zhao, Z.W., Zhang, M., Wang, G., et al. (2021) Astragalin Retards Atherosclerosis by Pro-moting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages. Journal of Cardiovascular Pharmacology, 77, 217-227. [Google Scholar] [CrossRef]
|
|
[20]
|
Franceschelli, S., De Cecco, F., Pesce, M., et al. (2023) Hy-droxytyrosol Reduces Foam Cell Formation and Endothelial Inflammation Regulating the PPARγ/LXRα/ABCA1 Path-way. International Journal of Molecular Sciences, 24, Article 2057. [Google Scholar] [CrossRef] [PubMed]
|